Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, Pilot Trial

Clinical trial NCT03367533 · COMPLETED

Trial details

NCT number: NCT03367533
Sponsor: Yale University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Depressive Disorder, Major Post Traumatic Stress Disorder Bipolar Disorder

Start date: 2018-11-29
Primary completion: 2022-07-08
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.